Similar to the effects of PD-1 blockade, the effects of blocking TIM-3 in vitro and ex vivo experiments demonstrated that it can improve cytotoxicity and IFN-γ release by both TILs and NK cells in RCC, melanoma, lung adenocarcinoma, and OC contexts [131]. Here, HAVCR2 is linked to melanoma.